To assess safety analysis of salvage therapy for advanced stages or metastatic lung cancers
Latest Information Update: 30 Jun 2022
At a glance
- Drugs Atezolizumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Lung cancer; Non-small cell lung cancer
- Focus Adverse reactions
Most Recent Events
- 30 Jun 2022 New trial record